EVIDENCE WATCH
A review and assessment of recent clinical trial data

Multiple myeloma
MAINTENANCE TREATMENT WITH THALIDOMIDE AFTER AUTOLOGOUS TRANSPLANTATION FOR MYELOMA: FIRST ANALYSIS OF A PROSPECTIVE RANDOMIZED STUDY OF THE INTERGROUPE FRANCOPHONE DU MYÉLOME (IFM 99 02).

Hematologic malignancy
MATCHED PAIRS ANALYSIS OF IV VS. PO BUSULFAN AS A CONDITIONING AGENT PRIOR TO TRANSPLANTATION.

 

To view the clinical trial data of the above topics click here (pdf format)
Back to Top of Page 

 

 
 
 
Oncology Exchange provides overviews of important clinical trial data presented at the 46TH Annual Meeting of the American Society of Hematology (ASH), December 4–7, 2004. Leading Canadian experts offer commentary and clinical interpretations. Contributors were selected by Douglas A. Stewart, MD, FRCPC, Tom Baker Cancer Centre, Calgary, AB.
 
© Parkhurst Publishing Privacy Statement
Legal Terms of Use
 Site created by Spin Design (514) 995-4398